12:00 AM
 | 
Aug 20, 2012
 |  BC Week In Review  |  Company News  |  Other News

Teva autoimmune, neurology, biosimilars news

Teva said that on July 9 it received a subpoena from the SEC to produce documents related to compliance with...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >